Marcelo Eduardo Bigal
Marcelo Eduardo Bigal
Head of the Merck Investigator Sudies Program, Scientific Engagements and Education
Email verificata su
Citata da
Citata da
Executive summary: heart disease and stroke statistics—2014 update: a report from the American Heart Association
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ...
Circulation 129 (3), 399-410, 2014
Migraine prevalence, disease burden, and the need for preventive therapy
RB Lipton, ME Bigal, M Diamond, F Freitag, ML Reed, WF Stewart
Neurology 68 (5), 343-349, 2007
Migraine and cardiovascular disease: systematic review and meta-analysis
M Schrks, PM Rist, ME Bigal, JE Buring, RB Lipton, T Kurth
Bmj 339, 2009
Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population‐based study
ME Bigal, D Serrano, D Buse, A Scher, WF Stewart, RB Lipton
Headache: The Journal of Head and Face Pain 48 (8), 1157-1168, 2008
Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment
ME Bigal, D Serrano, M Reed, RB Lipton
Neurology 71 (8), 559-566, 2008
Migraine: epidemiology, impact, and risk factors for progression
RB Lipton, ME Bigal
Headache: The Journal of Head and Face Pain 45, S3-S13, 2005
Efficacy and safety of topiramate for the treatment of chronic migraine: A randomized, double‐blind, placebo‐controlled trial
SD Silberstein, RB Lipton, DW Dodick, FG Freitag, N Ramadan, ...
Headache: The Journal of Head and Face Pain 47 (2), 170-180, 2007
Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study: CME
S Diamond, ME Bigal, S Silberstein, E Loder, M Reed, RB Lipton
Headache: The Journal of Head and Face Pain 47 (3), 355-363, 2007
Cutaneous allodynia in the migraine population
RB Lipton, ME Bigal, S Ashina, R Burstein, S Silberstein, ML Reed, ...
Annals of neurology 63 (2), 148-158, 2008
Obesity and migraine: a population study
ME Bigal, JN Liberman, RB Lipton
Neurology 66 (4), 545-550, 2006
Modifiable risk factors for migraine progression
ME Bigal, RB Lipton
Headache: The Journal of Head and Face Pain 46 (9), 1334-1343, 2006
Fremanezumab for the preventive treatment of chronic migraine
SD Silberstein, DW Dodick, ME Bigal, PP Yeung, PJ Goadsby, ...
New England Journal of Medicine 377 (22), 2113-2122, 2017
Migraine and cardiovascular disease: a population-based study
ME Bigal, T Kurth, N Santanello, D Buse, W Golden, M Robbins, ...
Neurology 74 (8), 628-635, 2010
Obesity is a risk factor for transformed migraine but not chronic tension-type headache
ME Bigal, RB Lipton
Neurology 67 (2), 252-257, 2006
Chronic disorders with episodic manifestations: focus on epilepsy and migraine
SR Haut, ME Bigal, RB Lipton
The Lancet Neurology 5 (2), 148-157, 2006
Classification of primary headaches
RB Lipton, ME Bigal, TJ Steiner, SD Silberstein, J Olesen
Neurology 63 (3), 427-435, 2004
Symptoms of temporomandibular disorders in the population: an epidemiological study.
DA de Godoi Gonalves, AL Dal Fabbro, JADB Campos, ME Bigal, ...
Journal of orofacial pain 24 (3), 2010
The epidemiology, burden, and comorbidities of migraine
ME Bigal, RB Lipton
Neurologic clinics 27 (2), 321-334, 2009
The International classification of headache disorders, 2nd edn (ICDH-II)
J Olesen, TJ Steiner
Journal of Neurology, Neurosurgery & Psychiatry 75 (6), 808-811, 2004
Prevalence and characteristics of allodynia in headache sufferers: a population study
ME Bigal, S Ashina, R Burstein, ML Reed, D Buse, D Serrano, RB Lipton
Neurology 70 (17), 1525-1533, 2008
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20